Search results for: Jorge Mestre-Ferrandiz
Filter search results
Defining the Complementarity of Medical Research Across Sectors in the UK
11 March 2014
…in similar therapeutic areas. Research under the grant is expected to be complete in mid 2015. The investigators on the grant are: Jon Sussex, Yan Feng and Jorge Mestre-Ferrandiz from…
Spotlight on OHE: Assessing Value and Balancing Needs in Health Care
15 December 2011
…for prescription medicines was the focus of several OHE activities during the third quarter of 2011. Jorge Mestre-Ferrandiz participated in a roundtable in Madrid, organized by Contenidos de Salud, that…
European Union Pharmaceutical Markets: A Case for Differential Pricing?
11 August 2015
…In a recently published article OHE’s Adrian Towse and Jorge Mestre-Ferrandiz, with colleagues, suggest ways to implement a differential pricing system for branded medicines in the EU that can enhance…
Cost Savings from Treating Obstructive Sleep Apnoea: OHE Consulting Report
26 September 2014
…please contact Jon Sussex at OHE. For information about OHE Consulting and its services, please contact Jorge Mestre-Ferrandiz. Download: Rejón-Parrilla, J.C., Garau, M. and Sussex, J., 2014. Obstructive sleep apnoea:…
OHE at ISPOR Europe 2: Conceptual and Practical Challenges in Judging Value
29 October 2014
…decision making. For OHE’s primer on MCDA, click here. 3. The Expanding Value Footprint of Oncology Treatments. Juan Carlos Rejon-Parrilla (OHE), Karla Herandez-Villafuerte (OHE), Koonal K Shah (OHE), Jorge Mestre-Ferrandiz…
OHE at ISPOR Europe: Posters
13 November 2014
… The Expanding Value Footprint of Oncology Treatments. Ispor poster expanding_value_footprint_oncology_treatment_jmf_oct2014 from Office of Health Economics Juan Carlos Rejon-Parrilla, Karla Hernandez-Villafuerte, Koonal Shah, Jorge Mestre-Ferrandiz, Lou Garrison and Adrian Towse…
Biosimilar Competition: Lessons from Europe and Prospects for the US
2 December 2014
…Biosimilars Competition: Lessons from Europe and Prospects for the US. London: Office of Health Economics. For further information on biosimilars, click here. For additional information, please contact Jorge Mestre-Ferrandiz…
New Business Models for Antibiotics. What Can We Learn from Other Industries?
7 April 2015
…AMR review group; as well as further work being done by US groups. The publication can be downloaded here. For further information contact Jorge Mestre-Ferrandiz at OHE. …
How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.
26 March 2020
…to Australia to speak at Antibiotics 2020 was funded by MSD (Merck & Co.) Related Research: Ferraro, J., Towse, A. and Mestre-Ferrandiz, J., 2017. Incentives for New Drugs to Tackle…